Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients

Fig. 2

Promoter methylation levels of panel #2 (APC, GSTP1, and  RARβ2) and miR-34b/c according to histologic grade group (a, b), respectively; Promoter methylation levels of APC according to CAPRA Score categories (c) and APC according to D’Amico risk group classification (d) in prostate biopsy tissue samples (cohort #1). (Mann-Whitney U test, **P < 0.01, *P < 0.05)

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us